Dr Frank James Canino, PHD | |
935 Park Ave Ste 200, Cranston, RI 02910-2748 | |
(401) 461-5618 | |
(401) 461-5618 |
Full Name | Dr Frank James Canino |
---|---|
Gender | Male |
Speciality | Clinical Psychologist |
Experience | 44 Years |
Location | 935 Park Ave Ste 200, Cranston, Rhode Island |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588752406 | NPI | - | NPPES |
1029870 | Other | RI | NEIGHBORHOOD HEALTH PLAN |
408999 | Other | RI | BLUE CHIP |
61-55329 | Other | RI | UNITED BEHAVIORAL HEALTH |
FC 43919 | Medicaid | RI | |
22616-3 | Other | RI | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PS00587 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Frank James Canino, PHD 112 Arnold Ave, Cranston, RI 02905-3814 Ph: (401) 785-2818 | Dr Frank James Canino, PHD 935 Park Ave Ste 200, Cranston, RI 02910-2748 Ph: (401) 461-5618 |
News Archive
A new and important genetic discovery, which sheds light on how prostate cancers develop and spread, has been made by an international research team led by scientists at The University of Nottingham.
Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has committed over $52.0 million in structured debt financing to new and existing portfolio companies.
This PATH Blog post examines PATH's work in malaria through OneWorld Health, a non-profit drug development program. Since 2004, "when OneWorld Health formed a partnership to develop an alternative source of the malaria drug artemisinin, ... OneWorld Health, which became an affiliate of PATH late last year, has quietly forged relationships with public and private partners, creating the Artemisinin Project to take the work from research to commercialization," the blog writes.
Boehringer Ingelheim today announced that the New Drug Application (NDA) for its investigational oncology compound afatinib has been accepted for filing and granted Priority Review by the U.S. Food and Drug Administration (FDA).
› Verified 7 days ago
Samantha A. Kirk, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 84 Bartlett Ave, Cranston, RI 02905 Phone: 401-243-7044 Fax: 401-842-0360 | |
Dr. Tonya Lynn Latzman, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 16 Walden Way, Cranston, RI 02921 Phone: 401-258-2627 | |
Amy Sisson, PSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 935 Park Avenue, Cranston, RI 02910 Phone: 401-781-4380 | |
Dr. Nelson Dias Martins, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 800 Oaklawn Ave, Cranston, RI 02920 Phone: 401-942-3300 Fax: 401-943-5492 | |
Dr. Hyun Jin Chung, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 789 Park Ave, Cranston, RI 02910 Phone: 401-421-4561 Fax: 401-243-3001 | |
Dr. Jill M Pfitzenmayer, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 1090 New London Ave, Cranston, RI 02920 Phone: 401-463-5778 Fax: 401-463-3592 | |
Mr. Michael Eric Schaffer, MA Psychologist Medicare: Medicare Enrolled Practice Location: 989 Reservoir Ave Ste 104, Cranston, RI 02910 Phone: 401-424-1846 |